The detection of platelet-related miRNA can be used as a potential biomarker for the diagnosis and prognosis of ITP, as well as to predict patients’ responses to TPO-RA treatment [16]. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.